Document Detail


Citrulline and albumin as biomarkers for gastrointestinal mucositis in recipients of hematopoietic SCT.
MedLine Citation:
PMID:  23334276     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Gastrointestinal (GI) mucositis is a common side effect of intense chemotherapy to prepare patients for hematopoietic SCT. Measuring intestinal damage objectively remains difficult, and clinicians often rely on albumin levels as an indicator of GI mucositis, but citrulline might be a more specific marker, which has in the past been shown to correlate with clinical signs of GI mucositis. We evaluated the courses of albumin and citrulline following different conditioning regimens for SCT and studied their relatedness to the subsequent inflammatory response using C-reactive protein. Patterns of albumin and citrulline differed significantly between myeloablative and non-myeloablative conditioning regimens. After myeloablative regimens, decreasing citrulline levels preceded the occurrence of inflammation unlike albumin levels, which decreased thereafter. Albumin levels were greatly influenced by inflammation, confirming it to be a 'negative acute-phase protein', whereas citrulline levels were not. Citrulline appeared to be a better biomarker of GI mucositis than albumin. Measuring citrulline might prove useful in clinical decision making, in identifying GI mucositis, and it would also be of interest to see how it compares with other biomarkers in the setting of acute GI GVHD.
Authors:
W J F M van der Velden; A H E Herbers; R J M Brüggemann; T Feuth; J Peter Donnelly; N M A Blijlevens
Related Documents :
2511386 - Factors modifying valproate plasma level/dose ratio: age, sex, dose and plasma level.
2396306 - Monitoring phenytoin therapy using citric acid-stimulated saliva in infants and children.
22149746 - Soluble transcobalamin receptor, scd320, is present in human serum and relates to serum...
7361796 - Phenytoin toxicity and blood levels after a large oral dose.
23105446 - Role of oxidative stress and antioxidants in aetiopathogenesis and management of oral s...
14575216 - A study on the serum levels of interleukin-1beta in bronchial asthma.
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study     Date:  2013-01-21
Journal Detail:
Title:  Bone marrow transplantation     Volume:  48     ISSN:  1476-5365     ISO Abbreviation:  Bone Marrow Transplant.     Publication Date:  2013 Jul 
Date Detail:
Created Date:  2013-07-03     Completed Date:  2014-02-04     Revised Date:  2014-06-10    
Medline Journal Info:
Nlm Unique ID:  8702459     Medline TA:  Bone Marrow Transplant     Country:  England    
Other Details:
Languages:  eng     Pagination:  977-81     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Allografts
Biological Markers / blood
Citrulline / blood*
Female
Graft vs Host Disease / blood*,  etiology
Hematologic Neoplasms / blood,  therapy
Hematopoietic Stem Cell Transplantation*
Humans
Male
Middle Aged
Mucositis / blood*,  etiology
Retrospective Studies
Serum Albumin / metabolism*
Transplantation Conditioning*
Grant Support
ID/Acronym/Agency:
090532//Wellcome Trust
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Serum Albumin; 29VT07BGDA/Citrulline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors...
Next Document:  Major ABO-incompatible BMT: isohemagglutinin reduction with plasma exchange is safe and avoids graft...